Increased TDO activity under these conditions leads to enhanced KP activity, as occurs in rheumatoid arthritis patients receiving long-term aspirin therapy exhibiting increased urinary excretion of Kyn, XA and 3-HAA [60]. This evidence concerns the gene NPPA and rheumatoid arthritis.